[144] BeOne Medicines Ltd. SEC Filing
ONC — Notice of proposed insider sale under Rule 144. A selling security holder filed a Form 144 to sell 10,000 common shares through Morgan Stanley Smith Barney LLC, with an aggregate market value $3,560,161.00. The shares are listed on NASDAQ, with an approximate sale date of 11/12/2025.
The filing lists prior acquisitions as restricted stock vesting under a registered plan across multiple dates, including 06/17/2023 (1,456 shares), 06/22/2023 (2,118), 06/05/2023 (4,291), 03/14/2024 (59), 09/15/2023 (52), 06/16/2023 (870), and 06/15/2024 (1,154). As context, shares outstanding were 109,663,273; this is a baseline figure, not the amount being offered.
The notice also reports sales in the past three months by Xiaobin Wu: 39,936 shares on 08/14/2025 for $12,180,813.46 and 49,858 shares on 08/13/2025 for $15,162,320.35.
- None.
- None.
Insights
Form 144 notice for up to 10,000 ONC shares; administrative.
This Form 144 records a proposed sale of 10,000 common shares with an
The filing enumerates how the seller acquired shares—restricted stock vesting on specific dates—and notes the listing on NASDAQ. It also discloses past three-month sales by Xiaobin Wu of 39,936 and 49,858 shares with reported proceeds figures.
Investor impact typically depends on execution and market conditions; this notice simply permits a sale consistent with Rule 144. Subsequent filings may provide execution details if transactions occur.